Market Closed -
Nasdaq
04:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
34.25
USD
|
-0.44%
|
|
+4.07%
|
-13.51%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,370
|
2,343
|
3,273
|
3,163
|
3,430
|
3,440
|
-
|
-
|
Enterprise Value (EV)
1 |
2,295
|
2,845
|
3,649
|
3,498
|
3,625
|
3,511
|
3,411
|
3,290
|
P/E ratio
|
51.8
x
|
70.2
x
|
81.4
x
|
29.2
x
|
26.1
x
|
22.3
x
|
20.2
x
|
17.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.53
x
|
2.87
x
|
3.25
x
|
2.71
x
|
2.76
x
|
2.64
x
|
2.52
x
|
2.4
x
|
EV / Revenue
|
4.38
x
|
3.48
x
|
3.63
x
|
2.99
x
|
2.92
x
|
2.69
x
|
2.5
x
|
2.3
x
|
EV / EBITDA
|
23.2
x
|
18.5
x
|
17.6
x
|
14.9
x
|
14.8
x
|
13.4
x
|
12.2
x
|
11
x
|
EV / FCF
|
31.9
x
|
49.7
x
|
28.9
x
|
33.2
x
|
22.7
x
|
20
x
|
17.4
x
|
16.5
x
|
FCF Yield
|
3.14%
|
2.01%
|
3.46%
|
3.01%
|
4.4%
|
4.99%
|
5.73%
|
6.07%
|
Price to Book
|
-
|
1.91
x
|
2.75
x
|
2.18
x
|
2.21
x
|
2.04
x
|
1.9
x
|
1.75
x
|
Nbr of stocks (in thousands)
|
81,754
|
95,380
|
95,780
|
100,371
|
99,549
|
99,989
|
-
|
-
|
Reference price
2 |
28.99
|
24.57
|
34.17
|
31.51
|
34.46
|
34.40
|
34.40
|
34.40
|
Announcement Date
|
10/29/19
|
10/26/20
|
10/22/21
|
10/21/22
|
10/24/23
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
523.4
|
816.6
|
1,006
|
1,169
|
1,243
|
1,304
|
1,367
|
1,432
|
EBITDA
1 |
98.72
|
153.9
|
207.3
|
234
|
245.6
|
262.5
|
278.8
|
299.6
|
EBIT
1 |
91.08
|
137.9
|
189.1
|
214.7
|
225.3
|
230
|
248.1
|
269.5
|
Operating Margin
|
17.4%
|
16.89%
|
18.8%
|
18.37%
|
18.13%
|
17.63%
|
18.16%
|
18.83%
|
Earnings before Tax (EBT)
1 |
64.29
|
48.03
|
80.86
|
150.6
|
175.7
|
212.9
|
237.6
|
267.4
|
Net income
1 |
47.54
|
34.7
|
40.88
|
108.6
|
133.6
|
155.9
|
171
|
195.5
|
Net margin
|
9.08%
|
4.25%
|
4.07%
|
9.29%
|
10.75%
|
11.95%
|
12.51%
|
13.66%
|
EPS
2 |
0.5600
|
0.3500
|
0.4200
|
1.080
|
1.320
|
1.541
|
1.704
|
1.980
|
Free Cash Flow
1 |
72
|
57.18
|
126.2
|
105.4
|
159.5
|
175.2
|
195.6
|
199.7
|
FCF margin
|
13.76%
|
7%
|
12.55%
|
9.02%
|
12.84%
|
13.43%
|
14.31%
|
13.95%
|
FCF Conversion (EBITDA)
|
72.94%
|
37.15%
|
60.88%
|
45.04%
|
64.97%
|
66.73%
|
70.15%
|
66.63%
|
FCF Conversion (Net income)
|
151.47%
|
164.8%
|
308.65%
|
97.08%
|
119.43%
|
112.37%
|
114.39%
|
102.11%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/29/19
|
10/26/20
|
10/22/21
|
10/21/22
|
10/24/23
|
-
|
-
|
-
|
Fiscal Period: August |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Net sales
1 |
281.3
|
296.7
|
316.5
|
274.2
|
300.9
|
296.6
|
324.8
|
320.4
|
308.7
|
312.2
|
334.3
|
347
|
327.6
|
328.4
|
355
|
EBITDA
1 |
65.62
|
54.18
|
63.29
|
50.96
|
60.77
|
50.9
|
66.64
|
67.25
|
61.96
|
57.84
|
69.3
|
73.41
|
67.11
|
61.89
|
74.21
|
EBIT
1 |
61.3
|
49.35
|
58.46
|
46.06
|
55.81
|
45.95
|
61.5
|
62.04
|
56.36
|
52.65
|
61.34
|
65.64
|
60.07
|
53.8
|
65.7
|
Operating Margin
|
21.79%
|
16.63%
|
18.47%
|
16.8%
|
18.55%
|
15.49%
|
18.93%
|
19.36%
|
18.26%
|
16.87%
|
18.35%
|
18.92%
|
18.34%
|
16.38%
|
18.51%
|
Earnings before Tax (EBT)
1 |
33.98
|
28.71
|
50.49
|
37.4
|
45.56
|
34.04
|
47.15
|
48.95
|
47.11
|
43.39
|
57.82
|
62.6
|
57.7
|
50.75
|
65.6
|
Net income
1 |
21.15
|
18.46
|
38.83
|
30.13
|
35.86
|
25.64
|
35.43
|
36.64
|
35.56
|
33.12
|
42.18
|
45.13
|
40.03
|
35.77
|
46.43
|
Net margin
|
7.52%
|
6.22%
|
12.27%
|
10.99%
|
11.92%
|
8.65%
|
10.91%
|
11.44%
|
11.52%
|
10.61%
|
12.62%
|
13.01%
|
12.22%
|
10.89%
|
13.08%
|
EPS
2 |
0.2200
|
0.1800
|
0.3800
|
0.3000
|
0.3600
|
0.2500
|
0.3500
|
0.3600
|
0.3500
|
0.3300
|
0.4167
|
0.4450
|
0.3967
|
0.3567
|
0.4600
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/5/22
|
4/6/22
|
6/30/22
|
10/21/22
|
1/5/23
|
4/5/23
|
6/29/23
|
10/24/23
|
1/4/24
|
4/4/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
501
|
376
|
336
|
194
|
71.2
|
-
|
-
|
Net Cash position
1 |
75.4
|
-
|
-
|
-
|
-
|
-
|
28.8
|
150
|
Leverage (Debt/EBITDA)
|
-
|
3.257
x
|
1.815
x
|
1.435
x
|
0.7904
x
|
0.2711
x
|
-
|
-
|
Free Cash Flow
1 |
72
|
57.2
|
126
|
105
|
160
|
175
|
196
|
200
|
ROE (net income / shareholders' equity)
|
-
|
3.35%
|
10.1%
|
8.26%
|
8.88%
|
10.6%
|
10.7%
|
10.8%
|
ROA (Net income/ Total Assets)
|
-
|
2.2%
|
6.04%
|
5.24%
|
6.37%
|
8.58%
|
8.79%
|
8.84%
|
Assets
1 |
-
|
1,575
|
676.6
|
2,073
|
2,096
|
1,818
|
1,946
|
2,211
|
Book Value Per Share
2 |
-
|
12.90
|
12.40
|
14.50
|
15.60
|
16.90
|
18.10
|
19.70
|
Cash Flow per Share
2 |
-
|
0.5800
|
1.350
|
1.100
|
1.700
|
1.900
|
2.110
|
2.180
|
Capex
1 |
1.04
|
1.74
|
5.91
|
5.23
|
11.6
|
8.05
|
7.67
|
7.93
|
Capex / Sales
|
0.2%
|
0.21%
|
0.59%
|
0.45%
|
0.93%
|
0.62%
|
0.56%
|
0.55%
|
Announcement Date
|
10/29/19
|
10/26/20
|
10/22/21
|
10/21/22
|
10/24/23
|
-
|
-
|
-
|
Last Close Price
34.4
USD Average target price
40.28
USD Spread / Average Target +17.08% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.51% | 3.44B | | +11.32% | 7.78B | | +1.64% | 7.38B | | +10.50% | 6.52B | | -6.69% | 3.67B | | -10.10% | 1.17B | | +8.34% | 934M | | -41.81% | 879M | | -19.81% | 836M | | -16.48% | 802M |
Special Foods & Wellbeing Products
|